MedPlus Health Services Limited
NSE:MEDPLUS.NS
680.2 (INR) • At close November 7, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) INR.
| 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2017 Q2 | 2017 Q1 | 2016 Q2 | 2016 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 14,888.25 | 14,904.98 | 14,414.72 | 14,085.89 | 12,842.96 | 12,529.83 | 11,903.14 | 11,206.25 | 9,936.54 | 9,420.03 | 9,334.53 | 9,247.38 | 9,551.81 | 7,872.32 | 8,009.88 | 7,312.78 | 7,312.78 | 5.23 | 5.23 | 5.62 | 5.62 |
| Cost of Revenue
| 13,814.21 | 13,737.12 | 11,227.38 | 11,041 | 10,108.93 | 9,699.78 | 9,265.09 | 8,778.61 | 7,833.4 | 7,600.09 | 7,396.39 | 7,390.48 | 7,436.79 | 6,407.21 | 6,398.24 | 5,731.925 | 5,731.925 | 0 | 0 | 0 | 0 |
| Gross Profit
| 1,074.04 | 1,167.86 | 3,187.34 | 3,044.89 | 2,734.03 | 2,830.05 | 2,638.05 | 2,427.64 | 2,103.14 | 1,819.94 | 1,938.14 | 1,856.9 | 2,115.02 | 1,465.11 | 1,611.64 | 1,580.855 | 1,580.855 | 5.23 | 5.23 | 5.62 | 5.62 |
| Gross Profit Ratio
| 0.072 | 0.078 | 0.221 | 0.216 | 0.213 | 0.226 | 0.222 | 0.217 | 0.212 | 0.193 | 0.208 | 0.201 | 0.221 | 0.186 | 0.201 | 0.216 | 0.216 | 1 | 1 | 1 | 1 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 0 | 0 | 0 | 0 | 0 | 415.23 | 0 | 0 | 0 | 330.94 | 0 | 0 | 0 | 791.8 | 0 | 900.68 | 900.68 | 0 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 112.6 | 0 | 0 | 0 | 67.82 | 0 | 0 | 0 | 16.78 | 0 | 3.455 | 3.455 | 0 | 0 | 0 | 0 |
| SG&A
| 736.71 | 701.34 | 674.25 | 616.06 | 1,475.98 | 527.83 | 482.78 | 483.23 | 397.15 | 398.76 | 320.22 | 322.31 | 884.9 | 808.58 | 796.33 | 904.135 | 904.135 | 0 | 0 | 0 | 0 |
| Other Expenses
| 87.12 | 104.59 | 97.91 | 103.65 | 93.93 | 136.94 | 113.61 | 108.93 | 101.3 | -79.66 | 73.34 | 67.7 | 42.1 | -60.48 | 87.84 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 736.71 | 701.34 | 2,840.65 | 2,748.71 | 2,544.74 | 2,571.76 | 2,378.71 | 2,249.68 | 1,957.68 | 1,602.23 | 1,627.86 | 1,512.36 | 1,420.61 | 1,100.71 | 1,248.17 | 1,279.325 | 1,279.325 | 55.43 | 55.43 | 9.525 | 9.525 |
| Operating Income
| 337.33 | 466.52 | 444.6 | 399.83 | 189.29 | 395.23 | 372.95 | 286.89 | 246.76 | 312.12 | 382.82 | 412.24 | 736.51 | 392.27 | 451.31 | 294.815 | 294.815 | -50.2 | -50.2 | -3.905 | -3.905 |
| Operating Income Ratio
| 0.023 | 0.031 | 0.031 | 0.028 | 0.015 | 0.032 | 0.031 | 0.026 | 0.025 | 0.033 | 0.041 | 0.045 | 0.077 | 0.05 | 0.056 | 0.04 | 0.04 | -9.598 | -9.598 | -0.695 | -0.695 |
| Total Other Income Expenses Net
| -159.46 | -146.67 | -244.98 | -235.39 | -138.78 | -222.69 | -210.82 | -198.66 | -198.1 | -185.77 | -165.31 | -160.82 | -152.38 | -134.06 | -131.3 | -108.435 | -108.435 | 0 | 0 | 0 | 0 |
| Income Before Tax
| 177.87 | 319.85 | 199.62 | 164.44 | 50.51 | 172.54 | 162.13 | 88.23 | 48.66 | 126.35 | 217.51 | 251.42 | 584.13 | 258.21 | 320.01 | 186.38 | 186.38 | -50.2 | -50.2 | -3.905 | -3.905 |
| Income Before Tax Ratio
| 0.012 | 0.021 | 0.014 | 0.012 | 0.004 | 0.014 | 0.014 | 0.008 | 0.005 | 0.013 | 0.023 | 0.027 | 0.061 | 0.033 | 0.04 | 0.025 | 0.025 | -9.598 | -9.598 | -0.695 | -0.695 |
| Income Tax Expense
| 34.43 | -15.76 | 62.57 | 19 | 12.86 | -93.05 | 28.32 | 23.45 | 11.87 | 12.03 | 48.34 | 51.36 | 120.54 | 77.39 | 92.42 | 75.03 | 75.03 | 0 | 0 | 0 | 0 |
| Net Income
| 143.63 | 333.96 | 137.26 | 145.64 | 37.86 | 265.83 | 134.07 | 65.65 | 32 | 117.28 | 171.73 | 203.13 | 465.89 | 183.53 | 229.09 | 112.98 | 112.98 | -50.2 | -50.2 | -3.905 | -3.905 |
| Net Income Ratio
| 0.01 | 0.022 | 0.01 | 0.01 | 0.003 | 0.021 | 0.011 | 0.006 | 0.003 | 0.012 | 0.018 | 0.022 | 0.049 | 0.023 | 0.029 | 0.015 | 0.015 | -9.598 | -9.598 | -0.695 | -0.695 |
| EPS
| 1.2 | 2.81 | 1.15 | 1.22 | 0.32 | 2.23 | 1.13 | 0.55 | 0.27 | 0.99 | 1.53 | 1.7 | 3.91 | 1.54 | 1.92 | 1.05 | 1.05 | -26.53 | -26.53 | 0 | 0 |
| EPS Diluted
| 1.2 | 2.79 | 1.14 | 1.21 | 0.32 | 2.23 | 1.13 | 0.55 | 0.27 | 0.99 | 1.52 | 1.7 | 3.91 | 1.54 | 1.92 | 1.04 | 1.04 | -26.53 | -26.53 | 0 | 0 |
| EBITDA
| 937.63 | 1,058.67 | 1,015.71 | 954.56 | 807.37 | 953.21 | 830.84 | 705.59 | 627.74 | 653.24 | 686.86 | 689.04 | 1,007.34 | 634.25 | 669.98 | 334.985 | 334.985 | -49.755 | -49.755 | 0 | 0 |
| EBITDA Ratio
| 0.063 | 0.071 | 0.07 | 0.068 | 0.063 | 0.076 | 0.07 | 0.063 | 0.063 | 0.069 | 0.074 | 0.075 | 0.105 | 0.081 | 0.084 | 0.046 | 0.046 | -9.513 | -9.513 | 0 | 0 |